Navigation Links
Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP

0 years of age, to 47.8% for those older than 60 years.(3)

"We are extremely encouraged by these PROMACTA results, and what this may mean for ITP patients," said Paolo Paoletti, M.D., Senior Vice President, Oncology Medicine Development Center, GSK. "This pivotal Phase III trial data and our ongoing efforts to assess the benefits of both short- and long-term treatment of PROMACTA will be part of GSK's commitment to work with regulatory authorities and ensure new treatment options for ITP patients are provided."

The Phase III trial was an international, randomized, double-blind, placebo-controlled study that enrolled 114 adults with chronic ITP and baseline platelet counts of <30,000/microliter. Eligible patients must have failed or stopped responding within three months of receiving one or more ITP therapies such as corticosteroids, immunoglobulins and/or splenectomy. Patients were allowed to continue on a concomitant ITP medication, provided their dose had been stable for at least a month prior to enrollment. These patients were randomized to either placebo (38 patients) or PROMACTA 50mg (76 patients) once daily for six weeks. The PROMACTA dose could be increased to 75mg in patients not responding after an initial three weeks of treatment. Patients were assessed for platelet count weekly and up to six weeks following treatment with PROMACTA. Bleeding events were assessed weekly using the World Health Organization (WHO) bleeding scale.(1)

At the end of the trial, 59% of PROMACTA treated patients and 16% of placebo treated patients achieved a platelet count of more than 50,000/microliter. Importantly, there was a significantly lower incidence of bleeding events during treatment with PROMACTA compared to placebo (p=0.029) with clinically significant bleeding (WHO Grades 2-4) observed in fewer PROMACTA patients (16%) than placebo patients (36%). The most common adverse event (AE) observed in this study was headache, reported in 8% and 11% of patien
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
2. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
3. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
4. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
5. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
6. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
7. Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
8. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
9. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
10. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
11. GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO
Post Your Comments:
(Date:2/27/2015)... , Feb. 27, 2015  Acsis Inc., the ... serialization solutions, announced today that John DiPalo , ... Supply & Demand Chain Executive 2015 Provider ... who are leading initiatives to help prepare their companies, ... today,s business climate. This year,s list of Provider Pros ...
(Date:2/27/2015)... Calif., Feb. 27, 2015 Isis Pharmaceuticals, Inc. ... outperformed both its pro forma net operating loss (NOL) ... a strong financial position.  Isis, significantly improved financial results ... $230 million in payments the Company received from its ... 2014 was a nearly 60% improvement over its 2013 ...
(Date:2/27/2015)... Report Details   Translational Regenerative ... and predicted revenues ,Where is the market for regenerative ... for this market and related technologies? Visiongain,s brand new ... 2025, discussing data, opportunities and prospects. ... : cell-based therapies that aim to restore function and ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... (DSMB) Authorizes Enrollment of Cervical ... Authorized Dosage Level, HOPKINTON, Mass., Sept. 24 ... independent Data,Safety Monitoring Board (DSMB) has unanimously authorized expanding ... injury (SCI) to,allow subjects with cervical SCI to be ...
... Enrollment Ahead of Schedule with Completion Expected Q2 ... Inc. (Nasdaq: ALTH ) today announced the ... safety data from the,Company,s pivotal Phase 2 PROPEL ... refractory peripheral T-cell lymphoma (PTCL). Results of,the interim ...
Cached Medicine Technology:Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 2Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 3Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 4Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 5Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 2Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 3Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 4Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 5
(Date:2/27/2015)... 2015 Victorian Hotel recently celebrated Valentine’s ... who wanted to spend the auspicious day together. This ... a jump on Valentine’s Day with a sweet overnight ... of their luxurious rooms. , The hotel started ... for a mouthwatering 3 course meal at Café 335. ...
(Date:2/27/2015)... 2015 Florida Hospital North Pinellas is ... Stroke Gold Plus hospital. In order to receive the ... adherence to all Get With The Guidelines - Stroke ... intervals and achieved 75-percent or higher compliance with six ... Measures. These are reporting initiatives to measure quality of ...
(Date:2/27/2015)... Calif. (PRWEB) February 27, 2015 The ... and research expertise have made it a beacon of ... and beyond, has been acknowledged by the national society ... the Huntington’s Disease Society of America — as ... , The acknowledgement recognizes the center’s service to over ...
(Date:2/27/2015)... 2015 The Nashville periodontist ... scholarship for rising freshmen undergraduate students. , The Advanced ... specializing in many periodontal procedures such as dental ... gum disease . In honor of their 25th anniversary, ... eligible rising freshmen undergraduate students. , Students interested ...
(Date:2/27/2015)... “ Logical Operations ” was featured ... which takes a look at the latest and coolest ... a special reporter for NewsWatch and a technology expert, ... company helps companies avoid cyber security threats. , If ... see cyber security somewhere in the headlines. Well, cyber ...
Breaking Medicine News(10 mins):Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2
... at Wake Forest University School of Medicine reveals that many ... immediate medical needs of a student or employee who suffers ... to support a new statewide program to place automated external ... to appear in the May/June 2009 issue of the ...
... (SIS) unveils SIS Trax, a tissue management solution that ... for hospitals to standardize their processes for acquiring, receiving, ... solution to be fully integrated with a perioperative information ... enables hospitals to improve patient safety, optimize revenue, reduce ...
... Conference Vice President for Public Policy Paul A. ... executive order to be issued by President Obama ... cell research:"President Obama,s executive order regrettably places ideology ... advancements. There are endless studies and stories ...
... Connectivity to be Presented at HIMSS09LOS ANGELES, ... (OTC Bulletin Board: FVRL), which through its ... provides Web-based consumer-controlled Personal Health Records ("PHRs") ... box storage solutions ( www.myesafedepositbox.com ), announced ...
... Chef Cat Cora ( www.catcoracooks.com ), ... Chef of Bon Appetit is excited to announce she ... her first pregnancy and the fourth child for the Cora family. ... deliver their third child, also a boy, in April. "Jennifer and ...
... Seen in Patient Delays and Unnecessary StaysCOLLEGE PARK, Md., March ... Maryland,s Robert H. Smith School of Business put a ... hospitals at $12 billion per year. The research, newly released ... is the first to quantify the economic impact of a ...
Cached Medicine News:Health News:Study prompts new mandate for N.C. high schools 2Health News:Study prompts new mandate for N.C. high schools 3Health News:SIS Trax Unveiled as First Fully Integrated Tissue Management Solution 2Health News:MyMedicalRecords Adds Enhanced Doctor-Patient Features to Its Flagship Personal Health Record Platform 2Health News:MyMedicalRecords Adds Enhanced Doctor-Patient Features to Its Flagship Personal Health Record Platform 3Health News:MyMedicalRecords Adds Enhanced Doctor-Patient Features to Its Flagship Personal Health Record Platform 4Health News:Celebrity Chef Cat Cora Announces First Pregnancy 2Health News:U.S. Hospitals Waste $12 Billion Annually Because of Poor Communication 2Health News:U.S. Hospitals Waste $12 Billion Annually Because of Poor Communication 3
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
... Tendril ST leads ... pacing leads, designed to ... reliability and flexibility to ... These pre-formed "J leads ...
RV Tracking for 100 % Resynchronization...
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
Medicine Products: